New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 14, 2014
20:25 EDTJASO, JASO, LMIA, LMIA, STRL, STRL, TNP, TNP, APRI, APRI, HNR, HNR, INO, INONotable companies reporting before Monday's open
Notable companies reporting before Monday's market open, with earnings consensus, include Apricus Biosciences (APRI), consensus (6c); Harvest Natural Resources (HNR), consensus 10c; Inovio Pharmaceuticals (INO), consensus (3c); JA Solar Holdings (JASO), consensus 1c; LMI Aerospace (LMIA), consensus 4c; Sterling Construction (STRL), consensus ($1.47); and Tsakos Energy Navigation (TNP), consensus (9c).
News For APRI;HNR;INO;JASO;LMIA;STRL;TNP From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
September 1, 2015
13:32 EDTTNPTsakos Energy announces two year charter renewal at 20% premium to prior rate
Tsakos Energy announced the charter renewal of a handysize product carrier to a major state oil company for a period of twenty-four months. This charter, commencing in September 2015, is at a 20% premium to the previous rate and is expected to generate approximately $13M in total gross revenues. As a result, this latest fixture along with the five charters announced last month, for a suezmax crude tanker and four MR product carriers, increases the total minimum charter revenues of the fleet under secured employment to over $750M.
07:05 EDTAPRIApricus Biosciences announces launch of Vitaros in Italy by Bracco
Subscribe for More Information
August 31, 2015
09:31 EDTJASOJA Solar initiated with a Sell at Axiom
Subscribe for More Information
07:01 EDTJASOJA Solar to supply 70MW of modules to Australia's Moree Solar Farm
Subscribe for More Information
August 25, 2015
11:41 EDTJASOSolarCity rises again after Chairman Musk buys shares
Subscribe for More Information
August 24, 2015
16:46 EDTJASOPresident Obama announces new renewable energy commitments
Subscribe for More Information
11:09 EDTJASOGoldman says SolarCity attractive after sharp pullback
SolarCity (SCTY) shares are climbing in the down market after Goldman Sachs contended in a note to investors today that the stock is attractive following its recent sharp retreat, The company probably won't be affected by issues that are causing investors to worry about the solar sector, the firm believes. WHAT'S NEW: Noting that SolarCity's stock had tumbled 27% in the last month before today's open, Goldman Sachs analyst Brian Lee wrote that the shares are being dragged down by worries about financing and cost of capital that are affecting the entire solar sector. However, he contended that these issues are having only a "limited" impact on SolarCity. On August 13, the company successfully sold asset-backed securities and it said that more such sales are likely to occur in the near-term, Lee noted. Meanwhile, SolarCity isn't being affected by the cost of capital increases that other solar companies are experiencing, the analyst reported. Before today's open, the stock was near a two year low, even though SolarCity's fundamentals are still "strong," Lee believes. Additionally, the largest U.S. solar trade show, which is expected to begin on September 14, could boost solar stocks, as it has historically been a catalyst for the sector, the analyst stated. SolarCity may provide guidance about the outlook for its Silevo solar panel manufacturing subsidiary in the second half of 2015, and the guidance could boost the stock, Lee believes. The risk/reward ratio of SolarCity's stock is positive, according to the analyst, who has a Conviction List Buy and $85 price target on the shares. OTHERS TO WATCH: Other publicly traded companies in the solar space include Canadian Solar (CSIQ), First Solar (FSLR), JA Solar (JASO), SunEdison (SUNE), SunPower (SPWR), Trina Solar (TSL) and Yingli Green Energy (YGE). PRICE ACTION: In late morning trading, SolarCity advanced 5.3% to $43.18.
August 21, 2015
06:56 EDTJASOSolar companies spending $1B in Texas projects, WSJ says
Subscribe for More Information
August 20, 2015
16:48 EDTAPRIOn The Fly: Top stock stories for Thursday
Subscribe for More Information
13:26 EDTAPRIOn The Fly: Top stock stories at midday
Subscribe for More Information
August 19, 2015
16:58 EDTAPRIOn The Fly: Top stock stories for Wednesday
The market opened deep in negative territory after a tumultuous trading session in China and a softer than expected U.S. consumer prices report. Sellers continued to push the averages lower throughout the morning, with the Dow tacking on losses of more than 200 points as investors waited for the release of the Fed minutes. The market rallied following an early leak of the minutes, which suggested officials are getting closer to raising rates but appear to be waiting for additional data. Despite the afternoon rally, the averages sold off once again heading into the close, leaving all three indices in the negatives for Wednesday. ECONOMIC EVENTS: In the U.S., the July consumer price index edged up 0.1% against expectations for 0.2% reading. The core reading, which excludes food and energy, also came in at 0.1% versus consensus estimates of 0.2%. There were no revisions to the 0.3% headline gain in June or the 0.2% growth in the ex-food and energy component. Component gains were muted across the board, with Energy prices up just 0.1% in July. Meanwhile, FOMC minutes showed no definitive indication of a September rate hike. Most committee members "judged that the conditions for policy firming had not yet been achieved, but they noted that conditions were approaching that point." Other members, however, believed that the inflation outlook "might not soon meet one of the conditions... for initiating a firming of policy." COMPANY NEWS: Shares of Dot Hill Systems (HILL) soared $4.50, or 86.87%, to $9.68 after Seagate Technology (STX) agreed to acquire the company for $9.75 per share, noting that it expects the deal to be non-GAAP EPS accretive in fiscal 2016. Shares of the hard drive giant fell 5.03% to $49.43 for the session... Lowe's (LOW) shares saw gains of $1.34, or 1.84%, to $74.36 following the company's earnings report this morning, while Target (TGT) rose $59c, or 0.73%, to $80.89 after beating on both top and bottom lines. On a subsequent conference call, Target executives forecast a "choppy" competitive environment in Q3, though they added that the company "will not get beat" on promotions in Q4. Separately, American Eagle (AEO) lost 7.42% to $16.92 after its quarterly numbers. MAJOR MOVERS: Among the notable gainers were Palatin (PTN) and Apricus (APRI), showing respective advances of 3.19% and 7.89% after the FDA approved Sprout's female sexual dysfunction drug Addyi, with the agency remarking that it "continues to encourage drug development in this area." Note that both Palatin and Apricus are developing their own treatments in the space, and Apricus reaffirmed this morning its intent to seek a global partner as it advances its Femprox sexual dysfunction medication. Also higher was Yum! Brands (YUM), which gained $1.90, or 2.26%, to $86.10 after appointing a new CEO of its China division, adding that its same-store sales in the region "have turned significantly positive." Among the noteworthy losers was Rayonier Advanced Materials (RYAM), plunging $6.01, or 44.09%, to $7.62 after disclosing a legal battle with its customer Eastman Chemical (EMN) over "meet or release" contract stipulations which may impact Eastman's purchase obligations. Also lower was Caesarstone (CSTE), which lost $3.43, or 7.14%, to $44.61 after short-selling hedge fund Spruce Point said the stock has up to 75% downside due to heightened raw material costs and competitive concerns, among other factors. Separately, EOG Resources (EOG), Baytex Energy (BTE), and Vanguard Natural (VNR) saw respective losses of 4.15%, 15.53%, and 13.83% after WTI crude fell 5.02% for the session. INDEXES: The Dow declined 162.61, or 0.93%, to 17,348.73, the Nasdaq fell 40.30, or 0.80%, to 5,019.05, and the S&P 500 lost 17.31, or 0.83%, to 2,079.61.
14:02 EDTINOInovio says DNA vaccine protects 100% against MERS virus in non-human primates
Inovio Pharmaceuticals announced its DNA vaccine targeting the virulent Middle East Respiratory Syndrome induced 100% protection from a live virus challenge in a preclinical study. This medical advancement is notable because there is no vaccine or effective treatment for the MERS virus, which is clearly able to transmit from human to human. Since 2012, MERS has infected 1,400 people and killed over 500. Recently, the largest outbreak outside of Saudi Arabia of this emergent global health concern infected 186 people with 36 fatalities in South Korea. In preclinical studies, Inovio and its collaborators evaluated its synthetic DNA-based MERS vaccine in mice, camels and monkeys, or non-human primates. In all three species, the vaccine induced robust immune responses capable of preventing the virus from infecting cells. The data from camels is an important finding because camels represent not only a host reservoir of the disease but act as a mode of transmission to humans. In monkeys, all vaccinated animals in the study were protected from symptoms of MERS disease when challenged with a live MERS virus. Inovio has reported on the preventive power of its synthetic DNA-based vaccines in a variety of infectious diseases including HIV, influenza, hepatitis B, Ebola and dengue.
13:30 EDTAPRIOn The Fly: Top stock stories at midday
Subscribe for More Information
07:03 EDTAPRIApricus Biosciences seeking global partner for Femprox
Subscribe for More Information
August 18, 2015
11:03 EDTJASOSunEdison raises capital while Trina Solar tops expectations
Subscribe for More Information
07:23 EDTSTRLBWS Financial to hold a conference
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the theflyonthewall.com disclaimer & terms of use